SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-321948
Filing Date
2018-11-08
Accepted
2018-11-08 08:13:05
Documents
3
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d562924d8k.htm 8-K 15585
2 EX-99.1 d562924dex991.htm EX-99.1 38647
3 GRAPHIC g562924dsp01.jpg GRAPHIC 2605
  Complete submission text file 0001193125-18-321948.txt   59109
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 181168263
SIC: 2834 Pharmaceutical Preparations